1. Targeting Channelrhodopsin-2 to ON-bipolar Cells With Vitreally Administered AAV Restores ON and OFF Visual Responses in Blind Mice
- Author
-
Serge Picaud, José-Alain Sahel, Antoine Chaffiol, Jens Duebel, Deniz Dalkara, Ernst Bamberg, Emilie Mace, Romain Caplette, Abhishek Sengupta, Olivier Marre, Melissa Desrosiers, Peggy Barbe, Marre, Olivier, Institut de la Vision, Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Max-Planck-Institut für Biophysik - Max Planck Institute of Biophysics (MPIBP), Max-Planck-Gesellschaft, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts (CHNO), and Fondation Ophtalmologique Adolphe de Rothschild [Paris]
- Subjects
Retinal Ganglion Cells ,Retinal degeneration ,Light ,genetic structures ,[SDV]Life Sciences [q-bio] ,Gene Expression ,Channelrhodopsin ,MESH: Dependovirus ,Blindness ,Photoreceptor cell ,Mice ,chemistry.chemical_compound ,MESH: Blindness ,MESH: Retinal Bipolar Cells ,MESH: Genetic Vectors ,Drug Discovery ,MESH: Behavior, Animal ,MESH: Animals ,Promoter Regions, Genetic ,Behavior, Animal ,Retinal Degeneration ,Gene Transfer Techniques ,Anatomy ,Dependovirus ,[SDV] Life Sciences [q-bio] ,medicine.anatomical_structure ,Intravitreal Injections ,Visual Perception ,Molecular Medicine ,MESH: Genetic Engineering ,Original Article ,Female ,Genetic Engineering ,Retinal Dystrophies ,MESH: Channelrhodopsins ,Retinal Bipolar Cells ,MESH: Gene Expression ,MESH: Retinal Degeneration ,MESH: Mice, Transgenic ,Genetic Vectors ,Mice, Transgenic ,MESH: Gene Transfer Techniques ,Optogenetics ,Gene delivery ,Biology ,MESH: Intravitreal Injections ,Channelrhodopsins ,MESH: Mice, Inbred C57BL ,MESH: Promoter Regions, Genetic ,Genetics ,medicine ,Animals ,Molecular Biology ,MESH: Mice ,Pharmacology ,MESH: Genetic Therapy ,Retina ,MESH: Visual Perception ,MESH: Vitreous Body ,Retinal ,MESH: Retinal Ganglion Cells ,Genetic Therapy ,medicine.disease ,eye diseases ,MESH: Light ,Mice, Inbred C57BL ,Vitreous Body ,chemistry ,sense organs ,Neuroscience ,MESH: Female - Abstract
International audience; Most inherited retinal dystrophies display progressive photoreceptor cell degeneration leading to severe visual impairment. Optogenetic reactivation of retinal neurons mediated by adeno-associated virus (AAV) gene therapy has the potential to restore vision regardless of patient-specific mutations. The challenge for clinical translatability is to restore a vision as close to natural vision as possible, while using a surgically safe delivery route for the fragile degenerated retina. To preserve the visual processing of the inner retina, we targeted ON bipolar cells, which are still present at late stages of disease. For safe gene delivery, we used a recently engineered AAV variant that can transduce the bipolar cells after injection into the eye's easily accessible vitreous humor. We show that AAV encoding channelrhodopsin under the ON bipolar cell-specific promoter mediates long-term gene delivery restricted to ON-bipolar cells after intravitreal administration. Channelrhodopsin expression in ON bipolar cells leads to restoration of ON and OFF responses at the retinal and cortical levels. Moreover, light-induced locomotory behavior is restored in treated blind mice. Our results support the clinical relevance of a minimally invasive AAV-mediated optogenetic therapy for visual restoration.
- Published
- 2015
- Full Text
- View/download PDF